SCHEMBL21233403

SCHEMBL21233403

[O-][S+]1COc2ccc(C3Oc4ccc(C5Oc6ccccc6O5)cc4S3)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18391368 0.93
SCHEMBL21778945 0.92
SCHEMBL18925131 0.85
SCHEMBL19492439 0.71 FAAH (0.32)
SCHEMBL19155331 0.69 FAAH (0.31)
SCHEMBL21787565 0.66 SLC5A2 (0.36)
SCHEMBL255955 0.65 ABCG2 (0.39)
SCHEMBL20078814 0.64 HTT (0.42)
SCHEMBL21324054 0.63
SCHEMBL24091489 0.63 LTA4H (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220133734-A1 SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-05 US disclosed
US-11077107-B2 Triazolopyrazine BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2021-08-03 US disclosed
US-20190240219-A1 TRIAZOLOPYRAZINE BOEHRINGER INGELHEIM INT (DE) 2019-08-08 US disclosed